We have limited Greek content available. View Greek content.

Kai Grass

Partner,

Dusseldorf

Passionate about Healthcare, Corporate M&A and Divestitures with global experience in developed and emerging markets

About Kai

Expertise

  • Interlock for M&A in Healthcare & Life Sciences
  • Co-author of Bain's 2023 M&A Report

Kai Grass is a member of our Healthcare & Life Sciences and M&A & Divestitures practices.

Kai’s healthcare work focuses on pharmaceutical and medtech clients. He has extensive experience in biopharma strategy and transformation in different topics such as R&D and clinical trials, M&A, commercial, pricing, and product launch, and emerging markets trends.

His recent client engagements have focused heavily on M&A and Divestiture topics for clients across industries. He is an authority on post-merger integration, carve-out/divestitures and separations, corporate M&A strategy and capability building, as well as value creation plans in post-acquisition situations.

Prior to joining the firm in 2009, he held research roles at Procter & Gamble and various academic institutions.

He holds a Ph.D. in Theoretical Physics from Goethe University, a diploma in physics from the University of Freiburg and a diploma in applied physics from the University of Auckland.

Recent Insights

Έτοιμοι να μιλήσουμε

Συνεργαζόμαστε με φιλόδοξους ηγέτες που θέλουν να καθορίσουν το μέλλον και όχι. Όχι να κρυφτούν από αυτό. Μαζί, επιτυγχάνουμε πετυχαίνουμε εξαιρετικά αποτελέσματα.